A randomized trial shows no significant difference in the primary endpoint of quality of life at 6 months between treatment with digoxin vs the beta-blocker bisoprolol (Zebeta) in patients with atrial ...
Please provide your email address to receive an email when new articles are posted on . At 6 months, quality of life in patients with permanent atrial fibrillation and symptomatic HF treated with ...
Researchers at the University of Illinois at Chicago have taken the dangerous guesswork out of dosing a lifesaving medication for congestive heart failure. A new formula developed in the UIC College ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results